LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Hetrick, Sarah E.; Thompson, Andrew D.; Yuen, Kally; Finch, Sue; Parker, Alexandra G. (2012)
Publisher: Biomed central
Journal: BMC Health Services Research
Languages: English
Types: Article
Subjects: RC, Research Article, Health Policy, RA1-1270, Public aspects of medicine

Abstract

Background

Literature has shown that dissemination of guidelines alone is insufficient to ensure that guideline recommendations are incorporated into every day clinical practice.

Methods

We aimed to investigate the gaps between guideline recommendations and clinical practice in the management of young people with depression by undertaking an audit of medical files in a catchment area public mental health service for 15 to 25 year olds in Melbourne, Australia.

Results

The results showed that the assessment and recording of depression severity to ensure appropriate treatment planning was not systematic nor consistent; that the majority of young people (74.5%) were prescribed an antidepressant before an adequate trial of psychotherapy was undertaken and that less than 50% were monitored for depression symptom improvement and antidepressant treatment emergent suicide related behaviours (35% and 30% respectively). Encouragingly 92% of first line prescriptions for those aged 18 years or under who were previously antidepressant-naïve was for fluoxetine as recommended.

Conclusions

This research has highlighted the need for targeted strategies to ensure effective implementation. These strategies might include practice system tools that allow for systematic monitoring of depression symptoms and adverse side effects, particularly suicide related behaviours. Additionally, youth specific psychotherapy that incorporates the most effective components for this age group, delivered in a youth friendly way would likely aid effective implementation of guideline recommendations for engagement in an adequate trial of psychotherapy before medication is initiated.

  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Cheung AH, Zuckerbrot RA, Jensen PS, Ghalib K, Laraque D, Stein REK, the GLAD-PC Steering Group: Guidelines for adolescent depression in primary care (GLAD-PC): II treatment and ongoing management. Pediatrics 2007, 120:e1313-1326.
    • 2. American Academy of Child and Adolescent Psychiatry (AACAP): Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adoles Psychiatry 2007, 46(11):1503-1526.
    • 3. National Institute for Health and Clinical Excellence NICE: Depression in Children and Young People: Identification and management in primary, community and secondary care. Leicester, UK: The British Psychological Society; 2005.
    • 4. McDermott B, Baigent M, Chanen A, Fraser L, Graetz B, Hayman N, Newman L, Parikh N, Peirce B, Proimos J, et al: beyondblue Expert Working Committee (2010) Clinical practice guidelines: Depression in adolescents and young adults. Melbourne: beyondblue: the national depression initiative; 2011.
    • 5. Grol R: Successes and Failures in the Implementation of Evidence-Based Guidelines for Clinical Practice. Med Care 2001, 39(8(suppl2)):II-46-II-54.
    • 6. Grol R: Personal paper: beliefs and evidence in changing clinical practice. Br Med J 1997, 315(7105):418-421.
    • 7. Bodenheimer T: The American health care system: the movement for improved quality in health care. New Engl J Med 1999, 340(6):488-492.
    • 8. Laughren TP: Clinical review: relationship between antidepressant drugs and suicidality in adults. In Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Silvers Spring, MD: FDA; 2006. http://www.fda.gov/ohrms/dockets/ac/06/briefing/ 2006-4272b1-01-fda.pdf.
    • 9. Dubicka B, Hadley S, Roberts C: Suicidal behaviour in youths with depression treated with new-generation antidepressants: meta-analysis. Br J Psychiatry 2006, 189:393-398.
    • 10. Hammad TA, Laugren T, Racoosin J: Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 2006, 63:332-339.
    • 11. Hetrick SE, McKenzie JE, Merry SN: The use of SSRIs in children and adolescents. Curr Opin Psychiatry 2010, 23:53-57.
    • 12. Goodyer IM, Wilkinson P, Dubicka B, Kelvin R: Forum: The use of selective serotonin reuptake inhibitors in depressed children and adolescents: commentary on the meta-analysis of Hetrick et al. Curr Opin Psychiatry 2010, 23:58-61.
    • 13. Hebebrand J, March J, Herpertz-Dahlmann B: Commentary on ;Forum: use of antidepressants in children and adolescents. Curr Opin Psychiatry 2010, 23:62-67.
    • 14. Dudley M, Hadzi-Pavlovic D, Andrews D, Perich T: New-generation antidepressants, suicide and depressed adolescents: how should clinicians respond to changing evidence. Aust NZ J Psychiatry 2008, 42:456-466.
    • 15. Hetrick SE, Simmons M, Thompson A, Parker AG: What are specialist mental health clinician attitudes to guideline recommendations for the treatment of depression in young people? Aust NZ J Psychiatry 2011, 45(11):993-1001.
    • 16. Nelson TD, Steele RG, Mize JA: Practitioner attitudes toward evidencebased practice: themes and challenges. Adm Policy Ment Health & Ment Health Serv Res 2006, 33:398-409.
    • 17. Wing JK, Curtis RH, Beevor AS: HoNOS: Health of the Nation Outcome Scales: Report on Research and Development July 1993-December 1995. London: Royal College of Psychiatrists; 1996.
    • 18. Stone M, Laughren T, Jones ML, Levenson M, Holland PC, Hughes A, Hammad TA, Temple R, Rochester G: Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. Br Med J 2009, 339:b2880.
    • 19. Morrato EH, Libby AM, Orton HD, de Gruy FV, Brent DA, Allen R, Valuck RJ: Frequency of provider contact after FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry 2008, 165:42-50.
    • 20. Brent DA, Emslie GJ, Clarke GN, Asarnow J, Spirito A, Ritz L, Vitiello B, Iyengar S, Birmaher B, Ryan ND, et al: Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study. Am J Psychiatry 2009, 166(4):418-426.
    • 21. Page AN, Swannell S, Martin G, Hollingworth S, Hickie IB, Hall WD: Sociodemograhpic correlates of antidepressant utilisation in Australia. Med J Aust 2009, 190:479-483.
    • 22. Perera A, Gupta P, Samuel R, Berg B: A survey of anti-depressant prescribing practice and the provision of psychological therapies in a South London CAMHS from 2003-2006. Child Adolesc Ment Health 2007, 12(2):70-72.
    • 23. Smith L, Gilhooly K, Walker A: Factors Influencing Prescribing Decisions in the Treatment of Depression: A Social Judgement Theory Approach. Appl Cognitie Psych 2003, 17:51-63.
    • 24. Young AS, Klap R, Sherbourne CD, Wells KB: The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry 2001, 58:55-61.
    • 25. Hepner KA, Rowe M, Rost K, Hickey SC, Sherbourne CD, Ford DE, Meredith LS, Rubenstein LV: The effect of adherence to practice guidelines on depression outcomes. Ann Intern Med 2007, 147(5):320-329.
    • 26. Linden M, Schotte K: A randomized controlled clinical trial on dosage selection and treatment outcome with doxepin comparing “guideline exposed” and “guideline naive” physicians. Pharmacopsychiatry 2007, 40:77-81.
    • 27. Lin EHB, Simon GE, Katzelnick DJ, Pearson SD: Does physician education on depression management improve treatment in primary care? Gen Intern Med 2001, 16:614-619.
    • 28. Worrall G, Angel J, Chaulk P, Robbins M: Effectiveness of an educational strategy to improve family physicians detection and management of depression:a randomized controlled trial. Can Med Assoc J 1999, 161(Pt1):37-40.
    • 29. Linden M, Westram A, Schmidt LG, Haag C: Impact of the WHO depression guideline on patient care by psychiatrists: a randomized controlled trial. Euro Psychiatry 2008, 23(6):403-408.
    • 30. Van Fenema E, Van Der Wee NJA, Bauer M, Witte CJ, Zitman FG: Assessing adherence to guidelines for common mental disorders in routine clinical practice. Int J Qual Health Care 2012, 24(1):72-79.
    • 31. Margolis KL, Solberg LI, Asche SE, Whitebird RR: Use of practice system tools by medical groups for depression. Am J Manag Care 2007, 13(1):305-311.
    • 32. Hetrick SE, Merry S, McKenzie J, Sindahl P, Proctor M: Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents (Review). In Cochrane Database of Systematic Reviews: The Cochrane Library.; 2007. Issue 3(Art. No.: CD004851. DOI: 10.1002/14651858).
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article